GlycoMimetics, Inc. - 54 Year Dividend History | GLYC
Historical dividend payout and yield for GlycoMimetics, Inc. (GLYC) since 1971. The current TTM dividend payout for GlycoMimetics, Inc. (GLYC) as of February 21, 2025 is $0.00. The current dividend yield for GlycoMimetics, Inc. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.019B |
$0.000B |
|
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
